The first LC-MS/MS stereoselective bioanalytical methods to quantitatively detect 9R- and 9S-hexahydrocannabinols and their metabolites in human blood, oral fluid and urine.

MLA

Kobidze, Giorgi, et al. “The First LC-MS/MS Stereoselective Bioanalytical Methods to Quantitatively Detect 9R- and 9S-Hexahydrocannabinols and Their Metabolites in Human Blood, Oral Fluid and Urine.” Journal of Pharmaceutical and Biomedical Analysis, vol. 240, Mar. 2024, p. 115918. EBSCOhost, https://doi.org/10.1016/j.jpba.2023.115918.

APA

Kobidze, G., Sprega, G., Montanari, E., Taoussi, O., Bambagiotti, G., Fede, M. S., Di Trana, A., Pichini, S., Busardò, F. P., Tini, A., Chankvetadze, B., & Faro, A. F. L. (2024). The first LC-MS/MS stereoselective bioanalytical methods to quantitatively detect 9R- and 9S-hexahydrocannabinols and their metabolites in human blood, oral fluid and urine. Journal of Pharmaceutical and Biomedical Analysis, 240, 115918. https://doi.org/10.1016/j.jpba.2023.115918

Chicago

Kobidze, Giorgi, Giorgia Sprega, Eva Montanari, Omayema Taoussi, Giulia Bambagiotti, Maria Sofia Fede, Annagiulia Di Trana, et al. 2024. “The First LC-MS/MS Stereoselective Bioanalytical Methods to Quantitatively Detect 9R- and 9S-Hexahydrocannabinols and Their Metabolites in Human Blood, Oral Fluid and Urine.” Journal of Pharmaceutical and Biomedical Analysis 240 (March): 115918. doi:10.1016/j.jpba.2023.115918.